Central serotonin (5-HT) function is thought to be a critical component of behavioral inhibition and impulse control. However, in recent clinical studies, 5-HT manipulations failed to affect stop-signal reaction time (SSRT), which is a fundamental process in behavioral inhibition. We investigated the effect of central 5-HT depletion (intracerebroventricular 5,7-dihydroxytryptamine) in rats on two aspects of behavioral inhibition, SSRT and 'waiting', using the stop-signal task. 5-HT depletion had no effects on SSRT or any other primary measure on the stop-signal task. However, within the same task, there was a deficit in 'waiting' in 5-HT-depleted rats when they were required to withhold from responding in the terminal element of the stop-signal task for an extended period. D-Amphetamine had dosedependent, but not 5-HT-dependent effects on SSRT. Conversely, the dose that tended to improve, or decrease, SSRT (0.3 mg/kg) impaired the ability to wait, again independently of 5-HT manipulation. These findings suggest that SSRT and 'waiting' are distinct measures of behavioral inhibition, and show that 5-HT is critical for some forms of behavioral inhibition but not others. This has significant implications for the treatment of conditions such as attention deficit and hyperactivity disorder, substance abuse, and affective disorders, in which inhibitory and impulse-control deficits are common.
INTRODUCTION
Central serotonin (5-HT) function is an important component of normal behavioral inhibition that controls impulsive responding (Evenden, 1999; Linnoila et al, 1983; Soubrié, 1986; Winstanley et al, 2006) . Pathological levels of inhibition failure and impulsivity are common to psychiatric conditions such as attention deficit and hyperactivity disorder (ADHD) (Aron and Poldrack, 2005; Oosterlaan et al, 1998; Rubia et al, 2007; Schachar et al, 1995) , Parkinson's disease (Gauggel et al, 2004; van den Wildenberg et al, 2006) , schizophrenia (Bellgrove et al, 2006) , obsessive-compulsive disorder (Chamberlain et al, 2005; Penades et al, 2007) , and chronic drug abuse (eg cocaine (Fillmore and Rush, 2002) , amphetamine , and methamphetamine (Monterosso et al, 2005) ).
Thus, abnormal 5-HT function may be central to the development of these conditions. Behavioral inhibition may have many elements, modulated by different brain regions or neurotransmitters (Dalley et al, 2008; Eagle et al, 2008; Pattij and Vanderschuren, 2008) . One commonly defined component, 'impulsive action', embraces any behavior in which the ability to inhibit actions is impaired. The dichotomy of 'impulsive action' and 'impulsive choice' is used to define models of impulse control that are central to the clinical assessment of ADHD in particular (Dalen et al, 2004; Sonuga-Barke, 2003) .
There are numerous behavioral tests of impulsive action that are considered to be directly comparable with one another, such as the continuous performance task (CPT) and its analogues in rat studies, the 5-choice serial reaction time (5-CSRT) task, differential reinforcement of low rates of responding (DRL) tasks, stop-signal tasks, and go/no-go tasks. Indeed, 5-HT function is linked with the modulation of impulsive action on many of these tests. For example, premature response control ('waiting') on the rat 5-CSRT task and human CPT is influenced by 5-HT receptor manipulations and central 5-HT depletion (Carli et al, 2006; Carli and Samanin, 2000; Dougherty et al, 2007; Harrison et al, 1997; Robinson et al, 2007; Walderhaug et al, 2002 Walderhaug et al, , 2008 . Furthermore, 5-HT depletion also impaired go/no-go inhibition in rats and hostile aggressive children with ADHD (Harrison et al, 1999; Masaki et al, 2006; Zepf et al, 2008) .
However, recent studies have consistently failed to find effects of 5-HT manipulations on the speed of the inhibitory process or stop-signal reaction time (SSRT), measured by the stop-signal task. Neither 5-HT depletion nor treatment with citalopram, a selective 5-HT reuptake inhibitor (SSRI), significantly affected SSRT in healthy human volunteers (Chamberlain et al, 2006; Clark et al, 2005) . Furthermore, the absence of effect of citalopram on SSRT was reproduced in rats , showing that the failure of 5-HT to influence this form of inhibition translates consistently across species.
If 5-HT manipulations have such different effects on two forms of impulsive action, this brings into question whether impulsive action represents a valid construct within a theory of behavioral inhibition and during clinical assessment of patients with impulse-control disorders. This is highlighted in a recent study that failed to find any significant relationship between CPT and stop-signal-task forms of impulsive action in adolescents (Reynolds et al, 2008) .
We investigated the effects of 5-HT depletion on SSRT and 'waiting' components of impulsive action control on the stop-signal task. Rats performed a rapid reaction time task and were required to withhold their response on a small percentage of stop trials following stop-signal presentation. The stop signal could be early or late in the trial, making it more or less possible to inhibit the response. To measure SSRT, stop-signals were presented close to the completion of the go response, requiring the motor response to be stopped well after its execution had begun. SSRT was estimated using a well-defined and -tested mathematical model, the race model (Logan and Cowan, 1984 ) (see Supplementary Information). To measure the ability to wait, the stop signal was presented at the start of each stop trial, and rats were required to withhold responding for an extended period, in trials comparable to extended ITI tests in the 5-CSRT task .
We also describe the effects of the stimulant D-amphetamine on SSRT and 'waiting' using the same task manipulations. Previous studies have shown that D-amphetamine decreased, or improved, long SSRTs in both rat and human studies Eagle and Robbins, 2003a; Feola et al, 2000) , but impaired the ability to wait in the 5-CSRT task, suggesting that these forms of behavior may be mediated through different neurotransmitter mechanisms.
MATERIALS AND METHODS

Subjects
Subjects were 24 male Lister-hooded rats (Charles River, UK), housed in groups of four in environmentally enriched cages. Experiments were conducted during the dark phase of a reversed 12-h light-dark cycle (lights off at 0730 hours). Rats weighed 275 ± 20 g initially and 410 ± 30 g at surgery, with weights maintained at approximately 90% of freefeeding weight (based on rat growth curves Harlan, UK). During testing, rats were fed 15-20 g of food per day (task reinforcer pellets plus laboratory chow given 1-2 h after the end of the daily test session), restricting weight gain to 1-2 g per week. All experiments were conducted in accordance with the United Kingdom Animals (Scientific Procedures) Act, 1986.
Experimental Design
Rats were trained in six operant-conditioning chambers, each with two retractable levers either side of a central food well (Med Associates, Vermont, USA). The protocol and training have been described in detail previously (Eagle and Robbins, 2003a, b) . A houselight in the roof of the chamber was on throughout the session. A pellet dispenser delivered 45-mg Noyes Formula P pellets (Sandown Scientific, Middlesex, UK) into the food well, and nose entry into the food well was monitored with an infrared detector. A center light, above the food well, signaled reinforcer delivery. Lights above the left and right levers signaled presentation of their respective levers. A 4500-Hz Sonalert tone generator (Med Associates) was mounted high on the wall opposite to the levers and food well. Control of the chambers and online data collection were conducted using the Whisker control system (Cardinal and Aitken, 2001) , using the Stop Task program, written by DM Eagle and JMC England. Rats were tested 5 days per week except during drug testing (see schedule below), and performed one 20-min session per day, with a maximum of 200 trials per session.
Each trial began with a nose poke to the central food well, after which the left lever and left light were presented (Figure 1) . A left-lever press resulted in presentation of the right lever and the left lever/light was withdrawn/extinguished. Rats responded rapidly between left lever and right lever pressesFthe 'go' response. Response speed was maintained by limiting the time for which the right lever was available, the limited hold (LH). The LH was set during training at a value that maintained the maximum performance of both fast, accurate go trials, and accurate no-delay stop trials. LH ranged between 0.9 and 2.65 s (mean ± SEM: 1.64±0.08), a constant value for each rat throughout the study. During go trials, rats were rewarded with one pellet for pressing the right lever but received a timeout of 5 s in darkness if the right lever was not pressed within the LH period.
A stop-signal tone (40 ms, 4500 Hz) was presented on 20% of the trials at a predetermined time between the left and right lever presses. Stop trials were randomized within the session to discourage anticipatory slowing of response speed. On 'stop' trials, rats initiated the same response as on go trials but following the stop signal they were required to withhold the right lever press for the duration of the LH period. A correctly withheld response was rewarded with one pellet and an incorrect stop-trial response (right lever press) gave a 5-s timeout. On a few trials designated as stop trials, the rat responded on the right lever before the stopsignal onset (more common for late tone presentations), and these trials were reclassified as go trials to maintain the overall proportion of valid stop trials in each session at 20%. Rats were trained to stable baseline performance (three consecutive days of greater than 70% accuracy on 5-HT depletion impairs waiting but not SSRT DM Eagle et al both stop and go trials with a fixed LH. Training was completed for all rats at session 35) before the experimental protocol began.
Experiment 1. Before lesionFone set of stop-signal delays (SSDs) to generate inhibition functions and calculate SSRT. Rats first completed three no-delay sessions to calculate mean GoRT for each individual. SSDs for each rat were relative to its own mean GoRT, which controlled for individual differences in GoRT. The inhibition function was measured over five sessions with SSDs presented in pseudo-randomized order (from the set GoRTÀ600 ms, GoRTÀ500 ms, GoRTÀ400 ms, GoRTÀ300 ms, GoRTÀ200 ms), with one SSD per session. Rats were lesioned, given 7 days recovery time post-surgery, then retrained to a stable baseline level of performance and retested with one experimental set of SSDs to produce an inhibition function and calculate SSRT.
Experiment 2. For selected points on the stop-trial inhibition function, rats were treated with D-amphetamine sulfate (0.3 and 1.0 mg/kg expressed in terms of the salt, dissolved in saline to form a solution of 0.3 or 1.0 mg/ml and injected intraperitoneally as 1.0 ml/kg) or saline vehicle.
These doses previously produced marked effects on the stop-signal task (Eagle and Robbins, 2003a A press on the left lever begins the 'go' response phase of the trial (e). The right lever is presented for a limited time, the limited hold, to promote rapid response. A right lever press (f) is rewarded (g). On 'stop' trials, during the response phase of the trial (e), a tone is played. The rat must suppress response on the right lever to attain reward (h). Incorrect responses (failure to press on go trials or right lever press on stop trials) result in a timeout period.
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was doubled (LH Â 2). This tested the ability to 'wait' or withhold pressing the right lever for the duration of the LH period. During the extended LH test, stop-signal trials were always presented with no delay, ie the stop signal occurred immediately after the left lever press at the beginning of the go trial. Performance at LH Â 2 was then stabilized over a further 4 days, after which rats were given one pair of extended LH Â 2 sessions with 0.3 mg/kg D-amphetamine or saline vehicle, presented within a balanced Latin-square design.
Spontaneous Locomotor Activity
Spontaneous locomotor activity was measured between experiments 2 and 3 using 16 computerized photocell beam activity cages (25 Â 40 Â 18 cm) with two photocell beams dividing the length of the cage into three equal parts. Each photocell beam was positioned 1 cm above the floor of the cage. The number of beam breaks was recorded over a 120-min period, separated into 5-min time bins, using an Acorn computer (Acorn Computers Ltd, Cambridge, UK). Cage allocation was randomized across experimental groups.
Surgery
Sham (n ¼ 12) and Lesion (n ¼ 12) groups were matched on pre-surgery task performance. All rats were treated 30 min before the start of surgery with 15 mg/kg desipramine HCl (Sigma Chemical Co., UK), dissolved in double-distilled water, to protect noradrenergic neurons from the neurotoxin. Rats were anesthetized with Avertin (10 g 99% 2,2,2-tribromoethanol (Sigma-Aldrich, Poole, UK) in 5 g tertiary amyl alcohol, diluted in a solution of 40 ml ethanol and 450 ml PBS), administered intraperitoneally as 1.0 ml/100 g rat, to induce anesthesia, and then as 1.0-ml intraperitoneal injections to maintain anesthesia. Rats were secured in a stereotaxic frame fitted with atraumatic earbars, and received bilateral intracerebroventricular (i.c.v.) infusions of 80 mg (free base) 5,7-dihydroxytryptamine (5,7-DHT) creatinine sulfate (Sigma Chemical Co.), dissolved in 10 ml of 0.1% ascorbic acid in saline, whereas the shams received bilateral i.c.v. infusions of 10 ml vehicle. Infusions were made bilaterally at coordinates AP À0.9 mm from bregma, L ± 1.5 mm from the midline, and DV À3.5 mm from dura, calculated from a stereotaxic atlas (Paxinos and Watson, 1986) . The incisor bar was set at À3.3 mm relative to the interaural line to give a flat skull position. Following each 8-min infusion, the injector was left in place for 2 min before withdrawal, to allow diffusion of the toxin/vehicle. Following surgery, animals were given free access to food for 5 days before behavioral testing to allow for the degeneration of serotonergic neurons (Bjorkland et al, 1975) .
Statistical Analysis
Behavioral data were subjected to analysis of variance using a general linear model with significance at a ¼ 0.05, using full-factorial models. Homogeneity of variance was verified using Levene's test. For repeated-measures analyses, Mauchly's test of sphericity was applied and the degrees of freedom corrected to more conservative values using the Huynh-Feldt epsilon for any terms involving factors in which the sphericity assumption was violated. Corrected degrees of freedom are shown to the nearest integer. Following repeated-measures analyses, simple one-way ANOVA or paired t-tests were used to investigate withinsubjects and between-subjects factors, with a-adjusted using Sidak's method (Howell, 1997) . P-values greater than 0.1 are reported as nonsignificant (NS). All figures show group means with error bars of ±1 SEM.
Ex Vivo Lesion Analysis
After completion of behavioral testing, rats were killed through exposure to increasing concentrations of carbon dioxide. The brains were rapidly removed and frozen on dry ice. Coronal sections were cut (150 mm thickness) on a cryostat (À101C) from the frontal pole to the hippocampus and mounted onto pre-chilled microscope slides. A stainless-steel micro-punch (0.75 mm diameter) and a razor blade were used to remove 0.4-2.0 mg aliquots of tissue from the following (left and right) brain regions on frozen slides: medial prefrontal cortex, dorsolateral and medial striatum, nucleus accumbens and hippocampus. Aliquots were weighed and samples homogenized in 100 ml of 0.2 M 5-HT depletion impairs waiting but not SSRT DM Eagle et al perchloric acid to precipitate protein material. Following centrifugation at 6000 r.p.m. for 20 min at 41C, 25 ml of supernatant was taken and placed into autoinjector microvials ready for analysis. Levels of 5-HT, noradrenaline (NA), and dopamine (DA) were determined in brain samples by reversed-phase, high-performance liquid chromatography, as described previously (Matthews et al, 2001; Winstanley et al, 2004a) .
RESULTS
ICV Neurochemistry
From the original 24 rats, 3 did not complete the study resulting in final group sizes of sham ¼ 10 and lesion ¼ 11. Postmortem analysis of monoamine concentrations throughout the forebrain revealed a profound reduction in 5-HT levels of greater than 90% for all of the regions assayed, compared with sham-operated controls ( (Harrison et al, 1999; Winstanley et al, 2003 Winstanley et al, , 2004b .
Preoperative Performance
Rats performed the stop-signal task within the constraints of the race model. All rats had normal inhibition functions, (Figure 2a : SSD F(3, 69) ¼ 12.11, po0.001) and delaydependent inhibition was independent of go-trial accuracy, which did not change significantly across stop-signal delays (SSD, F(4, 75) ¼ 0.32, NS; SSD Â Group F(4, 75) ¼ 0.37, NS).
Before surgery, prospective lesion groups were matched by LH (mean±SEM: control 1.64±0.15, 5-HT depletion 1.64 ± 0.09; Group F(1, 19) ¼ 0.01, NS), inhibition function (Group Â SSD F(3, 69) ¼ 0.86, NS), SSRT (Group F(1, 19) ¼ 0.55, NS), go-trial reaction time (GoRT; Group F(1, 19) ¼ 0.03, NS), stop, and go trial accuracy (in the 'nodelay' condition where the stop signal was presented at the start of the go trial (stop: Group F(1, 18) 
Postoperative Performance
There were no overall effects of 5-HT depletion on any aspect of baseline stop-signal task performance (Table 2) . 5-HT depletion did not affect reacquisition of baseline (nodelay) levels of stop or go accuracy over 10 days (stop, Group F(1, 19) 
Effects of D-Amphetamine
Systemic D-amphetamine produced dose-dependent effects on GoRT and SSRT. D-Amphetamine decreased GoRT, following 0.3 mg/kg D-amphetamine, but GoRT was slightly (nonsignificantly) increased following 1.0 mg/kg D-amphetamine ( No-delay stop-trial and go-trial accuracies were also significantly disrupted by D-amphetamine, particularly, by the highest dose, as observed in previous studies (Eagle and Robbins, 2003a) : the extent of this impairment for the 1.0 mg/kg dose probably affected estimated SSRT at that dose. Go-trial accuracy was impaired by both doses of D-amphetamine, with effect size increasing with dose ( Despite the clear effects of D-amphetamine on the stop task, there was no 5-HT-lesion-specific modulation of these effects on any measure of task performance: SSRT (Table 2: Group Â Dose F(1, 19) ¼ 0.15, NS); GoRT (Group Â Dose F(2, 29) ¼ 1.50, NS), stop-trial accuracy (Group Â Dose F(1, 24) ¼ 2.08, NS), or go-trial accuracy (Group Â Dose F(1, 24) ¼ 2.85, pp0.09).
Extended Limited Hold Test: Effects on Ability to Wait
In contrast to the lack of effect on SSRT, rats with 5-HT depletion were significantly less able to withhold responding, or wait, during an extended LH test, whereas control rats were not impaired during performance of this test After the initial test, rat performance under the new test condition of LH Â 2 was stabilized over a further four test sessions (Figure 3b) . Although there was an increase in the number of failed trials between the first and second session of LH Â 2 (comparison of hatched columns of Figure 3a with unfilled columns of Figure 3b : Day F(1, 19) ¼ 37.74, po0.001), both groups were affected to the same degree (Day Â Group F(1, 19) ¼ 0.00, NS), and the 5-HT-depleted group was still significantly less able to withhold responding than the control group (Group F(1, 19) ¼ 9.51, po0.01). This level of performance was stable for both groups across all four additional sessions of LH Â 2 (Day F(2, 43) ¼ 0.48, NS; Day Â Group F(2, 43) ¼ 0.22, NS). Critically, the 5-HTdepleted group remained significantly less able to withhold responding than the control group (Group F(1, 19 ¼ 7.71, pp0.01) , suggesting this deficit was not simply a difference in behavioral flexibility in response to the change in task requirements.
Following 0.3 mg/kg D-amphetamine treatment in the LH Â 2 condition, all rats were significantly impaired at withholding responding (Figure 3c : Dose F(1, 19) ¼ 9.53, po0.01; Dose Â Group F(1, 19) ¼ 1.00, NS). Further analysis showed that the amphetamine-induced waiting impairments were significant for both groups of rats (Control Dose F(1, 9) ¼ 10.86, po0.01; 5-HT depletion Dose F(1, 10) ¼ 9.03, pp0.013). The deficit in ability to wait during the extended LH period that was induced by the 5- There was no effect of D-amphetamine on go-trial accuracy (Dose F(1, 19) ¼ 1.51, NS; Group Â Dose F(1, 19) ¼ 0.10, NS), but GoRT was faster following D-amphetamine than saline (Dose F(1, 19) ¼ 9.34, po0.01), with no differences between control and 5-HT-depleted rats in the extent to which GoRT was speeded up by D-amphetamine (Group Â Dose F(1, 19) ¼ 0.77, NS).
Spontaneous Locomotor Activity
Rats with 5-HT depletion were more active than control subjects during the 120-min session ( 
DISCUSSION
The main findings of this investigation indicate that generalized depletion of brain 5-HT disrupts certain aspects of impulsive action but not others. These findings have profound implications for any theory that 5-HT modulates a global construct of 'behavioral inhibition', and also challenge hypotheses put forward in recent reviews that postulate the clear compartmentalization of inhibitory deficits into 'impulsive action' vs 'impulsive choice'. This study is the first to directly dissociate two important forms of impulsive action that have previously been considered as directly comparable in terms of their neural basis.
Central 5-HT depletion did not affect SSRT, ie the speed of an inferred inhibitory process required to stop an already initiated action, and yet rats were severely impaired in a modified version of the same task that assessed the ability to withhold such responding, or 'wait'. 5-HT depletion did not significantly affect any aspect of go-trial performance in either the SSRT or waiting tests, confirming that the impairments induced by 5-HT depletion were specific to inhibition and not to activation of responding. Treatment with D-amphetamine further dissociated SSRT and 'waiting' impairments: although there were no lesion-specific effects 
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of D-amphetamine, the dose that tended to decrease, or improve, SSRT (0.3 mg/kg) impaired waiting, and this was independent of 5-HT depletion.
The absence of SSRT deficits following 5-HT depletion was unlikely to have been the result of a failure to disrupt 5-HT transmission within the lesion group. 5-HT was significantly depleted in all sampled regions and there were profound behavioral effects on other aspects of the task. In addition to the 'waiting' deficit, 5-HT depletion increased locomotor activity in line with previous studies of spontaneous or conditioned locomotor activity (Gately et al, 1985; Williams et al, 1990; Winstanley et al, 2004a) . Therefore, 5-HT depletion leads to hyperactivity and impaired inhibition of response selection, but not to any effect on canceling a response in action.
These findings are of great significance in the light of recent clinical studies in which 5-HT manipulations had no effect on SSRT, and our study confirms that 5-HT is not critical to the concept of impulsive action. For both rat and healthy human subjects, neither 5-HT depletion nor treatment with the SSRI citalopram significantly influenced SSRT, thus showing clear evidence of cross-species translation of these null effects (Chamberlain et al, 2006; Clark et al, 2005; Eagle et al, 2008) .
The role of 5-HT in response inhibition might conceivably be critical to SSRT only if 'trial-by-trial performance was associated with motivational consequences in terms of either reinforcement or punishment' (Clark et al, 2005) , as many 5-HT-modulated behaviors have a component of reward/punishment-related feedback. Indeed, clinical studies of SSRT usually have no formal reinforcement of correct trials, although more recent studies have begun to assess the role of performance feedback (eg Reynolds et al, 2008) . However, our study showed that even in a foodreinforced stop-signal task there was no effect of 5-HT depletion on performance, and therefore, the failure to find effects of 5-HT depletion on SSRT in the clinical study was probably not because reinforcement was absent. It is more probable that 5-HT has little or no influence over SSRT.
The only evidence of a possible role for 5-HT in SSRT modulation comes from a clinical study of healthy volunteers with or without a family history of alcoholism (Crean et al, 2002) . The statistical significance of dietary tryptophan depletion in healthy volunteers with no family history of alcoholism was not reported but following tryptophan depletion their SSRTs were significantly lower than volunteers with a family history positive for alcoholism. Therefore, baseline impulsivity might have influenced the effectiveness of 5-HT depletion to disrupt SSRT. However, we found no evidence of baseline-dependent effects in our study: neither rats with high nor with low presurgical baseline SSRTs were susceptible to the effects of 5-HT depletion. Thus, in rats at least, baseline impulsivity did not influence the effects of 5-HT manipulations on SSRT.
In clear contrast to the lack of effect on SSRT, 5-HT depletion significantly impaired the ability to wait during an extended LH period on the stop-signal task. Such a difference in performance between the control and lesion groups on a brief, single-day test could potentially reflect altered behavioral flexibility, and thus a difference in the ability to respond to the changed task requirements. However, such a hypothesis would predict that both groups would stabilize to similar levels of performance. Clearly, this was not the case and the difference between groups in ability to withhold responding was stable across subsequent days of testing, suggesting that this impairment was indeed a robust 'waiting' impairment.
This form of impulse-control deficit most closely resembles the premature response deficit found in similar go/no-go tasks such as the 5-CSRT and DRL, both of which are markedly affected by manipulations of the 5-HT transmitter system. For example, 5-HT depletion (produced by either i.c.v. or intra-raphé 5,7-DHT infusion) profoundly and permanently increased premature responses in the 5-CSRT task (Carli and Samanin, 2000; Harrison et al, 1997; Winstanley et al, 2004a, b) , and increased responding (decreased correctly completed trials) (Fletcher, 1995) and decreased inter-response times (Wogar et al, 1992) during DRL schedules. Recent studies have shown that although 5-HT receptors are very strongly implicated in premature response control on the 5-CSRT task, the nature of this control over the ability to wait is complex, being both receptor-subtype-and site-dependent (Carli et al, 2006; Robinson et al, 2007; Winstanley et al, 2004b Winstanley et al, , 2006 . Central 5-HT manipulations also affect the ability to wait for reinforcement following response in impulsive-choice paradigms, although the evidence is less clear cut than for tests in which responding itself must be withheld. Although some studies have found direct effects of 5-HT manipulations on impulsive choice (Bizot et al, 1999; Mobini et al, 2000a, b; Schweighofer et al, 2008; Wogar et al, 1993) , others found no such effects (Crean et al, 2002; Tanaka et al, 2007; Winstanley et al, 2004a) . This discrepancy has been attributed to subtle differences between tasks. However, a recent study showed that such differences in impulsive choice could also be 5-HT-receptor specific, as impulsive responding was decreased following treatment with the 5-HT2 (C, B) receptor antagonist SER-082, but there were no effects of the 5-HT6 receptor antagonist SB-270146-A or the 5-HT2 (A, C) receptor antagonist, ketanserin on the same task (Talpos et al, 2006) . Nevertheless, even in the nulleffect studies there is some evidence that 5-HT function may be indirectly relevant to impulsive choice control. For example, in a task where i.c.v. 5-HT depletion produced no significant effects on impulsive choice of a small, immediate reward over a larger, delayed reward, 5-HT depletion did attenuate the subsequent ability of D-amphetamine to improve impulse control on this task (Winstanley et al, 2003) . This implies that 5-HT may be relevant to 'waiting' deficits within both 'impulsive action' and 'impulsive choice' categories, and furthermore, that SSRT may stand alone as a distinct form of behavioral inhibition in terms of modulation, or lack thereof, by 5-HT.
5-HT depletion impairs waiting but not SSRT
Central 5-HT depletion may disrupt 'waiting' because it impairs the ability to make accurate temporal judgments (Ho et al, 2002) . For example, impaired performance on a DRL 20-s schedule following 5-HT depletion improved when the internal-timing aspect of the task was removed. Thus, when rats were provided with a light cue to signal reinforcer availability, 5-HT-depleted rats quickly acquired the task (Fletcher, 1995) . Recent evidence from both human and rat studies confirm that specific 5-HT receptor subtypes may be involved in timing intervals of such magnitude (in the range of seconds to tens of seconds). For example, the 5-HT2A/1A receptor agonist psilocybin severely disrupted timing of intervals longer than 2-3 s in a range of tests with human subjects (Wittmann et al, 2007) , and both 5-HT 1A and, 5-HT2A receptor manipulations disrupted temporal differentiation in rats (Asgari et al, 2006; Body et al, 2003) . However, temporal differentiation on other tasks is not affected by 5-HT depletion (Chiang et al, 1999; Ho et al, 2002) , suggesting that such a straightforward link between 5-HT and the timing of waiting periods is too simplistic. Nevertheless, the importance of 5-HT receptors in both premature response control and some forms of temporal differentiation suggests a potentially key role for 5-HT in the accurate timing of extended waiting periods.
Relevant to the behavioral inhibition hypothesis, 5-HT depletion also impaired the ability to inhibit in go/no-go tasks, possibly because their ability to withhold responding was impaired (Harrison et al, 1999; Masaki et al, 2006) . However, conventional go/no-go tasks also contain a decision-making component in selectionFthe go or no-go response, and 5-HT function is clearly implicated in aspects of decision-making across species on other tasks such as reversal learning (Clark et al, 2004 (Clark et al, , 2005 Ruotsalainen et al, 1997; Ward et al, 1999) . Therefore, deficits in performance on go/no-go tasks following 5-HT manipulations may be a combination of impaired decision making and inability to withhold responding. In our study, the no-delay condition has many features in common with conventional go/no-go tasks, but the decision-making component of go vs no-go selection is absent as the go response should always be selected until a stop signal is superimposed upon it. 5-HT-depletion strongly impaired the ability to withhold responding when rats were required to wait for an extended period. This suggests that 5-HT is important, not only for maintaining inhibition once a response has been stopped, but also for the initial selection of inhibition over response. However, the speed at which the inhibitory process occurs in the first instance is not influenced by 5-HT mechanisms, in marked contrast with other data from both humans and rats showing significant effects of a selective NA-receptor blocker, atomoxetine, on SSRT (Chamberlain et al, 2006; Robinson et al, 2008) .
The opposite effects of D-amphetamine on the two forms of impulsive action to decrease, or improve, SSRT while impairing the ability to wait, further emphasize the differences between these two forms of impulsive action. D-Amphetamine produced characteristic speeding effects on GoRT during both experiments but had opposite effects on the two measures of inhibition. The effects of D-amphetamine on waiting are consistent with its effects to impair premature responding on the 5-CSRT task (Harrison et al, 1997) . This reinforces our hypothesis that 'waiting' and SSRT represent two different forms of inhibition that are differentially modulated in the brain.
This study challenges hypotheses put forward in recent reviews that postulate the compartmentalization of inhibitory deficits into 'impulsive action' vs 'impulsive choice'. This is important because these categories of inhibition are fundamental to the definition of conditions such as ADHD. In clinical assessment, 'waiting' deficits are considered to be equivalent to impaired SSRTs as measures of 'impulsive action'. However, with regard to 5-HT function these two measures are clearly dissociable and therefore not directly interchangeable indicators of 'impulsive action'. Indeed, SSRT appears to stand alone as a measure of behavioral inhibition that is highly resistant to 5-HT perturbations. We conclude that the concept of behavioral inhibition as it stands is insufficiently precise to account for the effects of 5-HT on behavior, which has fundamental implications for the clinical assessment of inhibitory dysfunction in conditions such as ADHD.
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